| Document |
Document Title |
|
WO/2000/003975A2 |
The invention relates to aryl vinyl ether derivatives of general formula (I), wherein the substituents are as defined in the description; compositions containing them, processes and intermediates for their preparation and a method of con...
|
|
WO/1999/065922A2 |
A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by five formulas (I), (II), (III), (IV), (V). Each of the R groups is defined in the disclosure.
|
|
WO/1999/062968A1 |
Methods for preparing olefin polymers, and catalysts for preparing olefin polymers are disclosed. The polymers can be prepared by contacting the corresponding monomers with a Group 8-10 transition metal catalyst and a solid support. The ...
|
|
WO/1999/059989A1 |
Process for preparing a benzo fused heterocyclo sulfonyl halide intermediate, comprising reacting a benzo fused heterocyclic compound with a -SO3- complex in the presence of a solvent and then adding oxalyl halide.
|
|
WO/1999/045922A1 |
A compound is provided having formula (I) wherein R?1¿ and R?2¿ independently denote a methylene, ethylene or unbranched or branched C¿3-16? alkylene, alkenylene or alkynylene group which is unsubstituted or substituted with one or mo...
|
|
WO/1999/040025A1 |
The invention concerns novel ionic compounds with low melting point whereof the onium type cation having at least a heteroatom such as N, O, S or P bearing the positive charge and whereof the anion includes, wholly or partially, at least...
|
|
WO/1999/036384A1 |
Alkenyldiarylmethane (ADAM) compounds have been found effective as anti-HIV agents. Novel ADAM compounds, their pharmaceutical formulations and a method of using same to treat viral infections are described.
|
|
WO/1999/033781A1 |
Compounds represented by formulae (I, II or III), wherein U is CH, O, or S; Z is -C(R¿2?)(R¿3?), -CH-N(R¿2?)(R¿3?), C(R¿3?)[(CH¿2?)nR¿2?], CH-C(R¿3?)(R¿8?)(CH¿2?)nR¿2?, C[(CH¿2?)nR¿2?]-[CH(R¿3?)(R¿8?)], C[(R¿3?)][CH[(CH¿...
|
|
WO/1999/028292A1 |
The invention concerns ionic compositions with high ionic conductivity, comprising a salt with delocalized anionic charge. An ionic composition comprises a salt dissolved in a solvent and has a conductivity higher than 10?-5¿ S.cm?-1¿ ...
|
|
WO/1999/028984A1 |
The invention concerns novel electrode materials derived from polyquinoid ionic compounds and their uses such as in electrochemical generators. It concerns in particular compounds such as a rhodizonic acid salt; a rufigallic acid salt; a...
|
|
WO/1999/024024A2 |
Retinoids with retinoid receptor antagonistic activity called retinoid antagonists, pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, have been found to be efficacious in the treatment of T-he...
|
|
WO/1999/020668A1 |
The invention relates to sulfone functionalized prepolymers useful in making high index of refraction optical lenses which have superior hardness and thermal stability. The invention further relates to the resins produced from the prepol...
|
|
WO/1999/006036A1 |
Certain retinoid derivatives, most or all of which are selective RXR retinoid agonists, have been found to be useful in the prevention or minimization of surgical adhesion formation.
|
|
WO/1998/058246A2 |
The invention provides compounds and intermediaries in their production useful as cation sensors and/or extractors, the compounds comprising a redox active group and a cation sensing group and/or a thiol terminating group. The compounds ...
|
|
WO/1998/052935A1 |
The invention concerns compounds of formula (I) in which: R�1?, R�2? and R�3? are as define in the description; X is as defined in the description; Y represents an oxygen atom, a sulphur atom, a CH�q?, SO or SO�2? group; n is b...
|
|
WO/1998/048806A1 |
The present invention provides a class of substituted indene compounds and their pharmaceutically acceptable salts which possess selective estrogen receptor modulator (SERM) activity and are thus useful in the treatment of osteoporosis a...
|
|
WO/1998/047933A1 |
Provided are certain transition metal complexes which are useful as catalysts in the polymerization of olefinic monomers. In particular, the invention provides complexes of certain bidentate ligands bonded to Ni, Pd, Co, or Fe, and optio...
|
|
WO/1998/046076A1 |
A method of inhibiting endothelin-1 in a subject comprising administering to the subject an inhibiting amount of a suitable retinoid or retinoid related molecule and a method of treating pain and diseases associated with the presence of ...
|
|
WO/1998/042661A1 |
An organic compound is provided which contains at least one nitric oxide donor group and at least one group being, or being adapted to be converted in vivo to a free sulfhydryl group. A preferred compound contains at least one sulfhydryl...
|
|
WO/1998/040420A2 |
The present invention includes novel ligands which may be utilized as part of a catalyst system. A catalyst system of the present invention is a transition metal-ligand complex. In particular, the catalyst system includes a transition me...
|
|
WO/1998/040374A2 |
Methods for preparing olefin polymers, or oligomers catalysts for preparing olefin polymers and bidentate ligand used for preparing these catalysts are disclosed. The polymers can be prepared containing the corresponding monomers with a ...
|
|
WO/1998/038185A1 |
The unsymmetrical linchpin coupling of 2-t-bityldimethylsilyl-1,3-dithiane with two electrophiles has been achieved as a single operation via solvent-controlled Brook rearrangement. The new protocol has also been extended to five-compone...
|
|
WO/1998/035955A1 |
The invention concerns novel monomers of formula A: (A) in which: Z represents H or CH�3? and X represents O or S, and Y is a heterocyclic compound consisting of hydrogen, carbon and sulphur atoms, having 5 to 8 chains and at least two...
|
|
WO/1998/023606A1 |
Cyclic dithio compounds of general formula I, wherein A is (a) or (b) [(wherein the substituents are each as defined in the claims)]; and remedies for diabetic kidney diseases, lenitives for digestive disorders, hypoglycemic agents or hy...
|
|
WO/1998/022423A1 |
The invention concerns novel bi-aromatic compounds of general formula (I): (I) and their use in pharmaceutical compositions for use as human or veterinary medicine (in particular for treating dermatological, rheumatic, respiratory, cardi...
|
|
WO/1998/022434A1 |
The invention relates to novel glyoxylic acid amides, a method for the production and the use thereof as pesticides.
|
|
WO/1998/018751A1 |
Compounds of 1,2-propane diol linked structure (I), when for use in therapy, wherein R?1� or R?2� comprises an acyl or fatty alcohol group derived from a C�12-30? preferably C�16-30? fatty acid desirably with two or more cis or t...
|
|
WO/1998/017630A1 |
The invention relates to novel amides of the general formula (I), a method for their production and their use as pesticides.
|
|
WO/1998/014436A1 |
The present invention relates to benzoxazinones of formula I, or stereoisomeric forms or mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical comp...
|
|
WO/1998/014418A1 |
Liqud crystal compounds and liquid crystal compositions which are best suited as a liquid crystal material required to have negative permittivity including an IPS mode. The compounds are represented by general formulae (1) and (1-1), whe...
|
|
WO/1998/003474A1 |
The invention concerns novel glyoxylic acid derivatives, a process for their preparation and their use as pesticides.
|
|
WO/1998/001440A2 |
The present invention is directed to pharmaceutical compositions including a saturated 1,2-dithiaheterocyclic compound having anti-viral activity. The present invention also provides a kit containing the pharmaceutical composition and me...
|
|
WO/1998/001441A1 |
Disclosed is (2-thione-1,3-dithiole 4,5-diyl)bis(thiocyanate), its preparation and its use as an antimicrobial and marine antifouling agent.
|
|
WO/1998/001442A1 |
Disclosed are (2-one (or thione)-1,3-dithiole-4,5-diyl)bis(thiomethylthiocyanate) compounds corresponding to formula (I) wherein Z is oxygen or sulfur, compositions containing said compounds and their use as antimicrobial and marine anti...
|
|
WO/1998/000411A1 |
A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by either of two formulas (I, II). Each of the R groups is defined in the disclosure.
|
|
WO/1997/048672A2 |
Compounds of formulas (1-6) where the symbols have the meaning described in the specification, have retinoid and/or retinoid antagonist-like biological acitivity.
|
|
WO/1997/043274A1 |
The present invention provides linker lipids for use in attaching a membrane including a plurality of ionophores to an electrode and providing a space between the membrane and the electrode. The membrane is either in part or totally made...
|
|
WO/1997/036863A1 |
The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated dise...
|
|
WO/1997/035929A1 |
Compositions containing conductivity enhancers, which are capable of being coated onto a substrate by means of electrostatic assistance. The compositions comprise one or more cationically polymerizable monomer(s), one or more cationic in...
|
|
WO/1997/030986A1 |
The invention concerns hetaroyl derivatives of formula (I) in which the substituents have the following meanings: L, M are hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkinyl, C1-C4 alkoxy, wherein these groups can optionally be substitu...
|
|
WO/1997/023476A1 |
Cyclic sulphones of formula (I) are disclosed, in which: R1 and R2 each independently of one another stand for H, A, CF3, CH2F, CHF2, C2F5, Hal, OH, OA, NH2, NHA, NA2, NO2 or CN; X stands for CR4R5, C=Z, O, S, NH, NA or NR3; Y stands for...
|
|
WO/1997/014667A1 |
The invention concerns novel bicyclic cyclopentane-1,3-dione derivatives of formula (I), in which A, B, B', G, Q, X, Y and Z have the meanings indicated in the description, a method of producing said derivatives and their use as pest-con...
|
|
WO/1997/014693A1 |
Compounds of general formula (I), in which R1 is C(CO2CH3)=CHOCH3, C(CO2CH3)=NOCH3, N(OCH3)CO2CH3 and C(CONHCH3)=NOCH3; R2 is cyano, halogen, C1-C4 alkyl and C1-C4 alkoxy; m is 0 or 1; R3 is cyano, halogen, C1-C4 alkyl, C1-C4 alkyl halid...
|
|
WO/1997/010270A1 |
New betaketosulfonic derivatives, the process for their preparation, the photopolymerizable systems containing the same and their application as polymerization photoinitiators for inks, and particularly for inks having high content of pi...
|
|
WO/1996/039128A1 |
Albumin particles in the nanometer and micrometer size range in an aqueous suspension are rendered stable against resolubilization without the aid of a cross-linking agent and without denaturation, by the incorporation of a stabilizing a...
|
|
WO/1996/038437A1 |
A process for the preparation of lipoic acid (thioctic acid), or a derivative thereof, is one in which a 2-substituted cyclohexanone is transformed in an oxidation reaction to a lactone having formula (I), wherein X is a heteroatom subst...
|
|
WO/1996/034846A1 |
Compounds of 1,3-propane diol linked structure (I), when for use in therapy, where R1 is an acyl or fatty alcohol group derived from a C12-30 preferably C16-30 fatty acid desirably with two or more cis or trans double bonds, and R2 is hy...
|
|
WO/1996/034855A1 |
Compounds of structure (I), and when for use in therapy: where R1 is an acyl group derived from a C16-30 fatty acid with two or more cis or trans double bonds and particularly an n-6 or n-3 series EFA or conjugated linoleic acid, or colu...
|
|
WO/1996/034858A1 |
Niacin as a compound, per se or for use in therapy, of structure (I), where B is -C(=O)- (nicotinic acid) or -CH2-O- (niacin alcohol), the "link" C which is optional is a diol or hydroxy carboxylic acid or dicarboxylic acid residue, and ...
|
|
WO/1996/033711A2 |
|
